Patents by Inventor Michael Scott VanNieuwenhze

Michael Scott VanNieuwenhze has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glycopeptide and preparation thereof
    Patent number: 7173107
    Abstract: The stereospecific synthesis of a glycopeptide using a triply orthogonal protection scheme is described, in particular, the synthesis of N-acetylglucosaminyl-?-[1,4]-N-acetylmuramylmonopeptide and derivatives thereof. The glycopeptide is useful for the preparation of GMDP and related compounds having a glucosaminyl-?-[1,4]-N-acetylmuramic acid disaccharide core.
    Type: Grant
    Filed: April 18, 2001
    Date of Patent: February 6, 2007
    Assignee: Eli Lilly and Company
    Inventors: Larry Chris Blaszczak, Elizabeth Anne Dingess-Hammond, William Joseph Hornback, Michael Scott VanNieuwenhze
  • Process for preparing lipid II
    Patent number: 7169919
    Abstract: A process is described for preparing a substrate for the transglycosylase enzymes of bacterial cell wall biosynthesis. The chemical synthesis makes available a sustainable and substantially pure source of supply of lipid II, including analogs thereof, that may be used in the identification of new therapeutic agents capable of disrupting steps in bacterial cell wall biosynthesis.
    Type: Grant
    Filed: April 18, 2001
    Date of Patent: January 30, 2007
    Assignee: Eli Lilly and Company
    Inventors: William Ernest Alborn, Jr., Larry Chris Blaszczak, Scott Carl Mauldin, Paul Luther Skatrud, Michael Scott VanNieuwenhze, Mohammad Sadegh Zia-Ebrahimi
  • PROCESS FOR PREPARING LIPID II
    Publication number: 20030027980
    Abstract: A process is described for preparing a substrate for the transglycosylase enzymes of bacterial cell wall biosynthesis. The chemical synthesis makes available a sustainable and substantially pure source of supply of lipid II, including analogs thereof, that may be used in the identification of new therapeutic agents capable of disrupting steps in bacterial cell wall biosynthesis.
    Type: Application
    Filed: April 18, 2001
    Publication date: February 6, 2003
    Inventors: Larry Chris Blaszczak , Michael Scott VanNieuwenhze , Mohammad Sadegh Zia-Ebrahimi , Scott Carl Mauldin , Paul Luther Skatrud , William Ernest Alborn